Detection of anti-ADAM 10 antibody in serum of a patient with pulmonary fibrosis associated with dermatomyositis

Annals of the Rheumatic Diseases

Volumn 58, Issue 12, 1999, Pages 770-772

  Fujita, Jiro ^a   Takeuchi, Tamotsu ^b   Dobashi, Naomi ^a   Ohtsuki, Yuji ^b   Tokuda, Michiaki ^a   Takahara, Jiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

^b KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIGEN DETECTION; ARTICLE; CASE REPORT; DERMATOMYOSITIS; DNA LIBRARY; FEMALE; HUMAN; HUMORAL IMMUNITY; LUNG FIBROSIS; PRIORITY JOURNAL;

EID: 0032727202     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.58.12.770     Document Type: Article

References (15)

1. 1 Crystal RG, Bitterman PB, Rennard SI, Hance AJ, Keogh BA. Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984;310:154-66.
2. 2 Corrin B, Dewar A, Rodriguez-Roisin R, Turner-Warwick M. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol 1985;147:107-19.
3. 3 Dreisen RB, Schwarz MI, Theofilopoulos AN, Stanford RE. Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med 1978;298:353-7.
4. 4 Erlinger R, Rauh G, Behr J, Schumacher U, Welsch U, Zolliner N. Similar frequency of autoantibodies against pneumocytes type II and Clara cells in patients with interstitial lung disease and healthy persons. Klin Wochenschr 1991;69:297-302.
5. 5 Meliconi R, Bestagno M, Sturani C, Negri C, Galavotti V, Sala C, et al. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue diseases. Clin Exp Immunol 1989;76:184-9.
6. 6 Ueda T, Ohta K, Suzuki N, Yamaguchi M, Hirai K, Horiuchi T, et al. High prevalence of serum antibodies to hepatitis C virus in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1992;146:266-8.
7. 7 Wallace WAH, Roberts SN, Caldwell H, Thornton E, Greening AP, Lamb D, et al. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis. Thorax 1994;49:218-24.
8. 8 Wallace WAH, Schofiels JA, Lamb D, Howie SEM. Localization of a pulmonary autoantigen in cryptogenic fibrosing alveolitis. Thorax 1994;49:1139-45.
9. 9 Dobashi N, Fujita J, Ohtsuki Y, Yamadori I, Yoshinouchi T, Kamei T, et al. Detection of anti-cytokeratin 8 antibody in sera of the patients with cryptogenic fibrosing alveolitis and pulmonary fibrosis associated with collagen vascular disorders. Thorax 1998;53:969-74.
10. 10 Chantry A, Glynn P. A novel metalloproteinase originally isolated from brain myelin membranes is present in many tissues. Biochem J 1990;268:245-8.
11. 11 Rosendahl MS, Ko SC, Long DL, Brewer MT, Rosenzweig B, Hedl E, et al. Identification and characterization of a pro-tumor necrosis factor-α-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem 1997; 272:24588-93.
12. 12 Lunn CA, Fan X, Dalie B, Miller K, Zavodny PJ, Narula SK, et al. Purification of ADAM 10 from bovine spleen as a TNFα convertase. FEBS Lett 1997;400:333-5.
13. 13 Wen C, Metzstein MM, Greenwald I. SUP-17, a Caenorhabditis elegans ADAM protein related to Drosophila KUZBANIAN, and its role in LIN-12/NOTCH signaling. Development 1997;124:4759-67.
14. 14 Wu E, Croucher PI, McKie N. Expression of members of the novel membrane linked metalloproteinase family ADAM in cells derived from a range of haematological malignancies. Biochem Biophys Res Commun 1997;235: 437-42.
15. 15 Mohler KM, Sleath PR, Fitzner JN, Cerretti DP, Alderson M, Kerwar SS, et al. Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 1994;370:218-20.